Otávio Clark, CEO of Evidências - Kantar Health, and Tobias Engel, medical analyst of Evidências - Kantar Health, attended the congress annual meeting of the American Society of Clinical Oncology (ASCO), that brought together more than 40.000 health professionals in Chicago, USA, from June 2 toRead more
To evaluate the patterns of treatment and use of health-related resources in patients with chronic idiopathic thrombocytopenic purpura, a rare autoimmune hematological disease. This was the objective of the study conducted by the Evidências – Kantar Health team that will be published in the Journal ofRead more
Evidências – Kantar Health is participating was present in the 22nd Annual International Meeting of the International Society For Pharmacoeconomics and Outcomes Research (ISPOR) with ten posters. The meeting is being held in Boston, United States, from May 20 to 24. ISPOR is one of the mostRead more
Evidências – Kantar Health is participating in the 22nd Annual International Meeting of the International Society For Pharmacoeconomics and Outcomes Research (ISPOR) with ten posters. The meeting is being held in Boston, United States, from May 20 to 24. ISPOR is one of the most importantRead more
We are a hub of healthcare solutions with the objective of solving problems through evidence-based medicine (EBM) techniques and assisting in decision making related to health technologies and market analysis. With strong leadership, our focus is to provide innovative solutions to improve global health by developing high-complexity case analysis, clinical trial design, courses and training, health technology reports, drug registration and incorporation of health technology dossiers, and economic studies. Combining passion for science with great commercial experience and deep knowledge of the Brazilian healthcare ...